Proposed FTC Ban on Noncompete Agreements Could Be Highly Disruptive to Lab Staffing
A proposed move to make noncompete agreements illegal could impact retention of some laboratory employees.
Compliance-nir
Subscribe today for access to
Articles and Reports
Normal Kickback and Billing Rules Return When PHE Ends on May 11
A look at the US end-of-emergency game plan and how it will impact lab compliance.
The Year in Lab Compliance: The 6 Biggest Stories of 2022
The year was certainly an interesting one in terms of regulatory change in the medical laboratory space.
CMS Proposes to Peel Back Restrictions on Physician Owned Hospital Expansions
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
January 1, 2021 Is D-Day for Hospital Pricing Transparency
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
How Coronavirus Public Health Emergency Offers Potential for Temporary Stark Relief
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
In Brief: OIG Opens Second Avenue for Anti-Kickback Statute Revisions
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
The Year in Labs Regulation: The 6 Biggest Stories of 2019
"May you live...
Stark Law: CMS Plan Would Make It Easier for Labs to Get Advisory Opinions
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
HIPAA: New HIPAA Penalties System Rewards Labs that Try to Comply
From - National Intelligence Report
New HHS rules significantly increase the amount of money your lab can save by making diligent and demonstrable efforts to prevent HIPAA violations even when…
DOJ Explains What It Wants from a Compliance Program
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
New OIG Report Confirms that Labs Are Still on the Enforcement Radar
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Compliance Alert: FDA Warning Letter to Inova Genomics Laboratory